AVTX
Price
$6.69
Change
+$0.06 (+0.90%)
Updated
Jul 25 closing price
Capitalization
72.44M
BDRX
Price
$0.88
Change
-$0.01 (-1.12%)
Updated
Jul 25 closing price
Capitalization
4.44M
Interact to see
Advertisement

AVTX vs BDRX

Header iconAVTX vs BDRX Comparison
Open Charts AVTX vs BDRXBanner chart's image
Avalo Therapeutics
Price$6.69
Change+$0.06 (+0.90%)
Volume$112.66K
Capitalization72.44M
Biodexa Pharmaceuticals
Price$0.88
Change-$0.01 (-1.12%)
Volume$129.51K
Capitalization4.44M
AVTX vs BDRX Comparison Chart in %
Loading...
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTX vs. BDRX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTX is a Hold and BDRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (AVTX: $6.69 vs. BDRX: $0.88)
Brand notoriety: AVTX and BDRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTX: 105% vs. BDRX: 5%
Market capitalization -- AVTX: $72.44M vs. BDRX: $4.44M
AVTX [@Biotechnology] is valued at $72.44M. BDRX’s [@Biotechnology] market capitalization is $4.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTX’s FA Score shows that 1 FA rating(s) are green whileBDRX’s FA Score has 1 green FA rating(s).

  • AVTX’s FA Score: 1 green, 4 red.
  • BDRX’s FA Score: 1 green, 4 red.
According to our system of comparison, AVTX is a better buy in the long-term than BDRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTX’s TA Score shows that 5 TA indicator(s) are bullish while BDRX’s TA Score has 5 bullish TA indicator(s).

  • AVTX’s TA Score: 5 bullish, 4 bearish.
  • BDRX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, BDRX is a better buy in the short-term than AVTX.

Price Growth

AVTX (@Biotechnology) experienced а +7.04% price change this week, while BDRX (@Biotechnology) price change was +4.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

AVTX is expected to report earnings on May 12, 2025.

BDRX is expected to report earnings on Apr 11, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVTX($72.4M) has a higher market cap than BDRX($4.45M). AVTX YTD gains are higher at: -9.960 vs. BDRX (-78.272).
AVTXBDRXAVTX / BDRX
Capitalization72.4M4.45M1,629%
EBITDA-50.14MN/A-
Gain YTD-9.960-78.27213%
P/E Ratio0.06N/A-
Revenue441KN/A-
Total Cash125MN/A-
Total Debt801KN/A-
FUNDAMENTALS RATINGS
AVTX vs BDRX: Fundamental Ratings
AVTX
BDRX
OUTLOOK RATING
1..100
2927
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
19
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
599
PRICE GROWTH RATING
1..100
4395
P/E GROWTH RATING
1..100
9795
SEASONALITY SCORE
1..100
n/a65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDRX's Valuation (19) in the Biotechnology industry is somewhat better than the same rating for AVTX (84) in the Pharmaceuticals Other industry. This means that BDRX’s stock grew somewhat faster than AVTX’s over the last 12 months.

BDRX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AVTX (100) in the Pharmaceuticals Other industry. This means that BDRX’s stock grew similarly to AVTX’s over the last 12 months.

AVTX's SMR Rating (5) in the Pharmaceuticals Other industry is significantly better than the same rating for BDRX (99) in the Biotechnology industry. This means that AVTX’s stock grew significantly faster than BDRX’s over the last 12 months.

AVTX's Price Growth Rating (43) in the Pharmaceuticals Other industry is somewhat better than the same rating for BDRX (95) in the Biotechnology industry. This means that AVTX’s stock grew somewhat faster than BDRX’s over the last 12 months.

BDRX's P/E Growth Rating (95) in the Biotechnology industry is in the same range as AVTX (97) in the Pharmaceuticals Other industry. This means that BDRX’s stock grew similarly to AVTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVTXBDRX
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 5 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
86%
Bullish Trend 5 days ago
75%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COUR12.373.29
+36.23%
Coursera
AVAH3.960.02
+0.51%
Aveanna Healthcare Holdings
CBAT1.03N/A
N/A
CBAK Energy Technology
IPG26.05-0.26
-0.99%
Interpublic Group of Companies (The)
AUUD4.51-0.12
-2.59%
Auddia Inc

AVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTX has been loosely correlated with FGEN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTX jumps, then FGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTX
1D Price
Change %
AVTX100%
+0.90%
FGEN - AVTX
57%
Loosely correlated
+3.04%
MEOBF - AVTX
46%
Loosely correlated
N/A
MRSN - AVTX
37%
Loosely correlated
-4.38%
PGEN - AVTX
34%
Loosely correlated
-1.87%
BDRX - AVTX
32%
Poorly correlated
-0.28%
More

BDRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDRX has been loosely correlated with LVTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BDRX jumps, then LVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDRX
1D Price
Change %
BDRX100%
-0.28%
LVTX - BDRX
41%
Loosely correlated
-2.05%
ATNF - BDRX
38%
Loosely correlated
+40.85%
KRRO - BDRX
33%
Loosely correlated
+0.69%
SCNI - BDRX
32%
Poorly correlated
-3.74%
AVTX - BDRX
32%
Poorly correlated
+0.90%
More